SCHEMBL7015556

SCHEMBL7015556

NC(CNc1ccccn1)c1ncc(Cc2ccccc2)c(-c2ccccc2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP1 P07148 1/20 0.41
FABP6 P51161 1/20 0.41
CYP2D6 P10635 1/20 0.40
GABRA5 P31644 1/20 0.37
PCSK9 Q8NBP7 1/20 0.37
FDPS P14324 1/20 0.36
CXCR4 P61073 1/20 0.36
LIMK2 P53671 1/20 0.35
HIF1A Q16665 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDR P35968 1/20 0.33
NTRK1 P04629 1/20 0.33
NTRK3 Q16288 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6644446 0.78 CYP2D6 (0.38) FABP1FABP6CYP2D6GABRA5FDPS
SCHEMBL7021148 0.75 CYP2D6 (0.46) FABP1FABP6CYP2D6GABRA5PCSK9
SCHEMBL3758388 0.69 CYP2D6 (0.66) FABP1FABP6CYP2D6PCSK9FDPS
SCHEMBL7022559 0.67 CYP2D6 (0.36) FABP1FABP6CYP2D6GABRA5PCSK9
SCHEMBL14198659 0.66 CYP2D6 (0.56) FABP1FABP6CYP2D6PCSK9FDPS
SCHEMBL1831588 0.66 CYP2D6 (0.56) FABP1FABP6CYP2D6PCSK9FDPS
SCHEMBL7854740 0.64 RAB9A (0.40) CYP2D6FDPSCXCR4KDM4EALDH1A1
SCHEMBL5094987 0.64 GABRA5 (0.43) FABP1FABP6CYP2D6GABRA5PCSK9
SCHEMBL17234281 0.62 CYP2D6 (0.58) FABP1FABP6CYP2D6FDPSCXCR4
SCHEMBL15208486 0.62 CYP2D6 (0.58) FABP1FABP6CYP2D6FDPSCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317433-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2003-06-11 EP disclosed
WO-2002020495-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2002-03-14 WO disclosed